Navigation Links
Insmed CEO Resigns Due to Health Concerns
Date:6/15/2009

l trial data may take longer than anticipated, competing products may be more successful, the biopharmaceutical industry may experience negative market trends, our continuing efforts to grow the business and develop IPLEX(TM) may be unsuccessful, the actual market for MMD may not actually match up with our external assessment, we may lack financial resources to complete development of product candidates and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

    Investor Relations Contact:
    Brian Ritchie - FD
    212-850-5683
    brian.ritchie@fd.com

    Media Relations Contact:
    Irma Gomez-Dib - FD
    212-850-5761
    irma.gomez-dib@fd.com


'/>"/>
SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Insmed Announces First Quarter 2009 Financial Results
2. Insmed Regains NASDAQ Compliance
3. Insmed to Host First Quarter 2009 Conference Call
4. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
5. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
6. Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
7. Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
8. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
9. Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference
10. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
11. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)...  An entire month is dedicated to one of ... disease (CMT) – a debilitating neuromuscular disease affecting the ... weakness, and foot and hand deformities. CMT affects 1 ... is a progressive disease, and over time patients lose ... such as leg braces, wheelchairs and scooters to get ...
(Date:9/19/2014)... Charlotte, NC (PRWEB) September 19, 2014 ... Certified Biobased Product Label for its Organic Cotton ... the product’s amount of renewable biobased ingredients meets or ... or intermediate materials composed in whole or in significant ... “This logo/label will allow our Organic cotton to be ...
(Date:9/18/2014)... 2014 Bipartisan passage this week by ... to stimulate development and commercialization of new technologies and ... leaders of SPIE, the international society for optics ... and Innovation (RAMI) Act, now moves to the full ... they are optimistic that it will win passage there ...
(Date:9/18/2014)...  Health Enhancement Products, Inc. (OTCQB: HEPI), a ... and metabolic processes, is pleased to announce the addition of ... Nola E. Masterson , a California ... September 17, 2014. "We,re very pleased and ... states Andrew Dahl , President and CEO. "She joins ...
Breaking Biology Technology:September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Barnhardt Manufacturing Company Earns USDA Certified Biobased Product Certification and Label for Organic Cotton 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2
... TROMS0, Norway, January 22 The Scandinavian-based drug,development company ... round to a total value of 73 million NOK ... early-stage clinical,development of two novel drugs. , ... the treatment of resistant,bacterial and fungal infections, as well ...
... Calif., Jan. 22 Abaxis, Inc. (Nasdaq: ABAX ... has scheduled a conference call to discuss its financial results ... 31, 2008. The call will be at 4:15 p.m. ET ... (706) 643-0580 to access the conference call, or can listen ...
... announced today that it has filed a new patent application for the ... ... TX (PRWEB) January 22, 2009 -- Stem Cell Innovations, Inc., (SCLL.PK) announced ... of pluripotent stem cells from primordial germ cells. "We have been ...
Cached Biology Technology:Lytix Closes USD 10.4 Million Funding Round 2Abaxis to Report Third Quarter Fiscal 2009 Financial Results Thursday, January 29, 2009 2Stem Cell Innovations, Inc., Files New Patent Application 2Stem Cell Innovations, Inc., Files New Patent Application 3
(Date:9/18/2014)... in DNA, tiny strands of nucleic acid that contain ... this genetic data, our DNA is copied into RNA ... perform tasks in our cells. , Several years ... Unlike all other known RNAs, this molecule is circular, ... abundant, little has been known about how they are ...
(Date:9/18/2014)... disciplines will be celebrated tonight at the third annual ... the health of premature infants and in paving the ... whose work was supported by the National Science Foundation, ... Energy Commission, will be honored at a ceremony at ... group of Members of Congress will be on hand ...
(Date:9/18/2014)... the fish world, are the ideal animal in which ... moved from the ocean into tens of thousands of ... changing their skeleton to adapt to the new environment. ... sticklebacks now have turned up one of the genes ... change in that gene,s regulation in a freshwater population ...
Breaking Biology News(10 mins):Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 23rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3
... , , , , , ... AUDIO: Kathryn E. Henderson, PhD, Director of School and Community Initiatives at the Yale ... Click here for more information. , , , ... , , , , , ...
... The lucrative crops grow with a minimal amount of work ... that are ideal for bioenergy production come with a drawback ... billions of dollars in economic damage. Careful introduction of ... increasingly critical, as is the evaluation of new or bioengineered ...
... that the sense of taste is complicated is an understatement, ... cells transmit taste information to the brain for three out ... mystery, until now. , A team of investigators from nine ... is released as the neurotransmitter from sweet, bitter, and umami, ...
Cached Biology News:Stronger support needed for healthy beverage practices in child care 2Stronger support needed for healthy beverage practices in child care 3Stronger support needed for healthy beverage practices in child care 4Researchers propose new solution to ensure biofuel plants don't become noxious weeds 2Researchers propose new solution to ensure biofuel plants don't become noxious weeds 3How the body's energy molecule transmits 3 types of taste to the brain 2